Carmen M. Lago-Orizales
Leganes, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prediction of preterm pre-eclampsia and preterm small-for-gestational-age at 24-28 weeks of gestation using ultrasound and biochemical markers in high-risk pregnancies treated with aspirin: A secondary analysis of the StopPRE trial.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: June 10, 2026
Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised Trial.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: March 11, 2025
Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: May 10, 2024
Mid-trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre-eclampsia: Post-hoc analysis of StopPRE trial.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: April 28, 2023
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial.
Journal: JAMA
Published: February 22, 2023
Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women.
Journal: Viruses
Published: December 14, 2020
The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis.
Journal: BMC pregnancy and childbirth
Published: October 21, 2020
Emerging and imported diseases diagnosed in the emergency department of a hospital in Madrid.
Journal: Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias
Published: September 28, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026